Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555


Report Image
Top 10 Diabetes Care Technologies, Devices and Therapeutics Market - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020
Upcoming: Oct-2014    |    Formats: PDF & Excel    |    Code: ME 1462    |   
  • Report
    Overview
  • Table of
    Contents
  • Research
    Methodology

Diabetes care market comprises of technologies, devices and therapeutics markets in relation to diabetes. As estimated by The World Diabetes Foundation, there would be 438 million people suffering from diabetes by 2030. Approximately 11.6% of the global healthcare expenditure is shared by diabetes care. In 2010, global expenditure on diabetes was $376 billion. Global diabetes management product market was valued $41 billion in 2012. Sedentary lifestyle and obesity are primary factors driving the diabetes care market. There has been a considerable rise in the number of diabetes cases globally over the last few years. Improper diet and sedentary lifestyle are the main risk-elevating factors. Currently, about 528.7 million people are suffering from obesity, which is a primary reason for development of diabetes in people.

Reimbursement issues would be the primary factor restraining market growth during the analysis period. In April 2013, CMS slashed the reimbursements provided for diabetes testing supplies. Further, third party reimbursements are restricted to the type of coverage they provide concerning devices, diagnosis and treatment of diabetes.

Key Players profiled in the report include Glaxosmithkline, Abbott Laboratories, Johnson & Johnson, Bayer AG, Novartis International AG, Roche, Sanofi, Takeda and Merck & Co. Ltd.

KEY BENEFITS

  • Market analysis based on current market scenario and expected future trends to enable stakeholders take strategic decisions
  • Analysis of the factors impacting the market to understand business opportunities
  • Analysis of the market based on devices and geography as well as forecast from 2013 to 2020
  • Identification of key investment pockets for various applications, services and geographies
  • Identification of the key players and their strategic moves
  • Implications of the regulations and reimbursement scenario in diabetes care
  • Evaluation of market trends to provide deep-dive intelligence into every market segment
  • Competitive analysis to effectively plan and execute business plan
  • Micro level analysis based on application, service and geography

 MARKET SEGMENTS

GLOBAL MARKET,  BY DEVICES

  • Insulin Delivery
    • Syringes
    • Pens
    • Injectors
    • Inhaled Insulin
    • Insulin Pumps
  • Blood Glucose Monitoring
    • Lancets
    • Blood Sampling Devices
    • Blood Glucose Meters
  • Other Glucose Testing Devices
    • Hemoglobin A1c
    • Hemoglobin A1c Meters
    • Hemoglobin A1c Kits

GLOBAL MARKET,  BY GEOGRAPHY

  • North America
  • Europe, Middle East & Africa
  • Asia-Pacific
  • Latin America

 KEY AUDIENCES

  • Diabetes instrument manufacturers
  • Diabetes therapy providers
  • Hospitals and Clinics
  • Pathological Laboratories

         

Please fill in the form below to get a TOC

* Marked Fields are Mandatory






image



Can't read the image? click here to refresh
     
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
SIMILAR MARKET STUDIES

Published Reports

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
3 Jun 2014 | Price: $4515(SU) | View Details >>

The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 4.9% during 2013-2020. Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the total infertility is due to male factors. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing to the rise in male infertility levels. The major limitation experienced in the male infertility market is due to repeated treatment failures leading to an emotional impact on the patient.
29 Apr 2014 | Price: $4515(SU) | View Details >>

The advancement of IVF market in Asia Pacific is characterized by major factors such as the rising standards of living and growing number of couples delaying parenthood due to professional and financial commitments. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. As the chances of conceiving lowers with age, delayed pregnancy in women is one of the major driving factors of the IVF market. The success rate of getting pregnant with IVF technique is higher within the age group of 35-39. Other driving factors of the IVF market are rise in infertility rates due to rise in stress levels, change in life style and fertility related diseases.
18 Mar 2014 | Price: $5315(SU) | View Details >>

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.
29 Jan 2014 | Price: $4515(SU) | View Details >>

Traditional wound care & closure and advanced wound care & closure products are used to treat acute and chronic wounds. Chronic wounds are hard to heal wounds, which take substantial time to heal and are expensive to treat. Advanced wound care & closure products are emerging as a standard solution for treating chronic wounds.
22 Jul 2014 | Price: $4515(SU) | View Details >>

Upcoming Reports

Vital signs, such as breathing rate, temperature, heartbeat and blood pressure are essential in measuring, monitoring and keeping a watch on basic body functioning. Vital signs devices thus play an important role in maintaining health as they monitor various vital parameters. The vital signs monitoring market comprises of services and devices for emergency care and support. The inclination of patients towards treatment at home as opposed to hospitals in order to cut costs is a significant trend witnessed in this market
Price: $4515 | Pre Book Price: $3950 | View Details >>

Renal Denervation is a novel approach for the treatment of resistant hypertension. It is an invasive, endovascular catheter based procedure that involves the use of radiofrequency ablation. Several devices have been approved for this procedure. The incidence of hypertension has been increasing worldwide, despite the availability of effective anti-hypertensive medicines.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Sports medicine is a branch of medicine that deals with the prevention and treatment of injuries incurred during sports activities, exercises or physical fitness training. Sports medicine devices therefore, include a wide range of products utilized for the prevention, recovery and cure of injuries related to the above physical activities. These injuries consist of fractures, sprains, soft tissue damage, joint dislocation, strain and musculoskeletal injuries.
Price: $4515 | Pre Book Price: $3950 | View Details >>

Spectrometry is an analytical technique that assists in the identification of compounds and elements. This identification is based on the measurement of radiant energy emitted by a substance when in a higher energy state. Spectrometry instruments play a vital role in the analytical, pharmaceutical and life science industry. These industries have witnessed a growing demand for spectrometric instruments as they form an integral part of basic research and are used in drug composition identification, identification of new compounds and metals and bimolecular analysis. Due to its significant applications in different industries,
Price: $4515 | Pre Book Price: $3950 | View Details >>

Medical gases are meant to be administered to a patient for therapeutic, diagnostic or anesthetic purposes. These gases have wide application in healthcare. They are produced, distributed and facilitated through means of medical gas equipment. The main driver for this market is the U.S. Food and Drug Administration Safety and Innovation Act, implemented in July 2012,that enables manufacturers to control costs and to file for intellectual property rights for new medical gas and equipment products.
Price: $4515 | Pre Book Price: $3950 | View Details >>
First time Buyer ?
Check offer and
discount on this report


Request Quote



Pre Book Price
Original Price
$3950
$4515



WHY ALLIED MARKET RESEARCH?
INFALLIBLE METHODOLOGY
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader






Top